These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2230373)

  • 1. [Effects of immunoglobulin preparations on the opsonic activities against various pathogens].
    Ono Y; Baba M; Ouyatsu I; Nozue N; Ueda Y; Haga T; Guuji A; Nishiya H; Kobayashi K; Kunii O
    Kansenshogaku Zasshi; 1990 Jul; 64(7):854-60. PubMed ID: 2230373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity assessment of human intravenous immunoglobulin preparations against drug-resistant bacteria.
    Ono Y; Ito T; Watanabe T; Koshio O; Tansho S; Ikeda T; Kawakami S; Miyazawa Y
    J Infect Chemother; 2004 Aug; 10(4):234-8. PubMed ID: 15365865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of opsonophagocytic dysfunctions in severely burned patients by luminol-dependent chemiluminescence.
    Ono Y; Kunii O; Kobayashi K; Kanegasaki S
    Microbiol Immunol; 1993; 37(7):563-71. PubMed ID: 7694055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis.
    Clark LA; Easmon CS
    J Clin Pathol; 1986 Aug; 39(8):856-60. PubMed ID: 3745476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic activity of sera and blister fluid from severely burned patients evaluated by a chemiluminescence method.
    Ono Y; Kunii O; Suzuki H; Ikeda H; Kobayashi K; Kanegasaki S
    Microbiol Immunol; 1994; 38(5):373-7. PubMed ID: 7935062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of biological activity of immunoglobulin preparations by using opsonized micro-organisms to stimulate neutrophil chemiluminescence.
    Munro CS; Stanley PJ; Cole PJ
    Clin Exp Immunol; 1985 Jul; 61(1):183-8. PubMed ID: 3930107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states.
    Stevens P; Winston DJ; Van Dyke K
    Infect Immun; 1978 Oct; 22(1):41-51. PubMed ID: 215546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic activity of myeloma immunoglobulins (MM-Ig).
    Cheson BD
    Am J Hematol; 1981 Dec; 11(4):347-53. PubMed ID: 7331990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis.
    Tertti R; Granfors K; Lahesmaa-Rantala R; Toivanen A
    Clin Exp Immunol; 1989 May; 76(2):227-32. PubMed ID: 2758695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemiluminescence and phagocytic responses of rat polymorphonuclear neutrophils to leptospires.
    Isogai E; Isogai H; Wakizaka H; Miura H; Kurebayashi Y
    Zentralbl Bakteriol; 1989 Nov; 272(1):36-46. PubMed ID: 2610812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.
    Cutler CW; Kalmar JR; Arnold RR
    Infect Immun; 1991 Jun; 59(6):2097-104. PubMed ID: 2037370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates.
    Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the opsonic activity of purified bovine sIgA following intramammary immunization of cows with Staphylococcus aureus.
    Barrio MB; Rainard P; Gilbert FB; Poutrel B
    J Dairy Sci; 2003 Sep; 86(9):2884-94. PubMed ID: 14507024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE; Cruess DF; Fischer GW
    Pediatr Infect Dis J; 1994 Dec; 13(12):1122-5. PubMed ID: 7892082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
    Gordon DL; Rice JL
    Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis.
    Christensen RD; Brown MS; Hall DC; Lassiter HA; Hill HR
    J Pediatr; 1991 Apr; 118(4 Pt 1):606-14. PubMed ID: 1901083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood.
    Ono Y; Watanabe T; Matsumoto K; Ito T; Kunii O; Goldstein E
    J Infect Chemother; 2004 Aug; 10(4):200-7. PubMed ID: 15365859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.